We are live on ! Find out more
MXCT icon

MaxCyte
MXCT

120 hedge funds and large institutions have $268M invested in MaxCyte in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 51 increasing their positions, 30 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 6

70% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 30

5% more funds holding

Funds holding: 114 → 120 (+6)

0.04% more ownership

Funds ownership: 65.37% → 65.4% (+0.04%)

0% less capital invested

Capital invested by funds: $269M → $268M (-$582K)

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

56% less call options, than puts

Call options by funds: $4K | Put options by funds: $9K

Holders
120
Holders Change
+6
Holders Change %
+5.26%
% of All Funds
1.72%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
12
Increased
51
Reduced
30
Closed
6
Calls
$4K
Puts
$9K
Net Calls
-$5K
Net Calls Change
+$1K

Top Buyers

1
CP
CenterBook Partners
Connecticut
+$2.47M
2
CCM
Cadian Capital Management
New York
+$2.38M
3
SAM
Silvercrest Asset Management
New York
+$1.62M
4
BlackRock
BlackRock
New York
+$1.46M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$959K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$4.15M
2
BWLSA
Blue Water Life Science Advisors
California
-$2.37M
3
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$1.96M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.84M
5
PCM
Portolan Capital Management
Massachusetts
-$1.62M
Name Holding Trade Value Shares
Change 		Change in
Stake
Carson Wealth (CWM LLC)
126
Carson Wealth (CWM LLC)
Nebraska
– +$51 +12 +17%
2 3 4 5
6

MXCT Hedge Fund Activity: Q3 2024 in Review

120 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q3 2024, worth a combined $268M — down 0.22% from $269M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new MXCT positions and 6 closed out — a net gain of 6 holders — while 51 added to existing stakes and 30 trimmed.

The largest buyer was CenterBook Partners, opening a new position worth an estimated $2.47M. The largest seller was Millennium Management, cutting an estimated $4.15M.

  • 120 institutional investors held MaxCyte (MXCT) as of Q3 2024, up from 114 in Q2 2024.
  • Funds reported $268M of MaxCyte stock for Q3 2024, down 0.22% quarter-over-quarter.
  • 12 funds opened new MaxCyte positions in Q3 2024 and 6 closed out, a net change of +6 holders.
  • The largest MaxCyte buyer in Q3 2024 was CenterBook Partners, an estimated $2.47M added.
  • The largest MaxCyte seller in Q3 2024 was Millennium Management, an estimated $4.15M sold.

Based on aggregated 13F filings for Q3 2024.